Authors
George R Thompson, Neil M Ampel, Nathan C Bahr, Tom Chiller, Claudia E Frola, Nelesh P Govender, Thomas J Walsh, Emmanuel Roilides, Marisa H Miceli, Alessandro C Pasqualotto, Rob Purdie, Flavio Queiroz-Telles, Andrej Spec, Rosanne Sprute, Thuy Le, Ana Alastruey-Izquierdo
Published in
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Endemic mycoses, caused by Blastomyces, Coccidioides, Emergomyces, Histoplasma, Paracoccidioides, Sporothrix, and Talaromyces marneffei, represent an important global health challenge. Expanding endemic regions, climatic change, improved diagnostics, increased disease awareness, and an increasing at-risk population have contributed to rising case numbers. These infections affect both immunocompetent and immunocompromised hosts and exhibit marked clinical heterogeneity. Current treatment response guidance, established by the Mycoses Study Group and the European Organization for Research and Treatment of Cancer in 2008, are primarily tailored for invasive yeast and mold infections and are inadequate for endemic mycoses due to their complexity and heterogeneity.
An international, multidisciplinary expert panel convened through the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology to develop consensus guidance for treatment response assessment in endemic mycoses. The process included a structured literature review, expert discussion, regulatory consultation, patient input, and public comment, culminating in consensus-based response criteria.
The proposed guidance response criteria encompass clinical, mycologic, and radiologic assessments.
The new criteria aim to improve the accuracy and standardize the assessment of treatment response, enabling comparison and pooling results across clinical trials while addressing the unique challenges posed by these diverse pathogens.
PMID:
43043169
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0